← Leaderboards
Mary E Wohl
Children'S Hospital Boston
$1,334
Attributed
$1,334
Total exposure
3
Grants
0
Lead (contact PI)
Attributed= this PI's even-split share of every grant they're on (the fair, additive number). Exposure = full size of all those grants. They are the sole PI on all grants (the two match).
Funding mix
By agency
NIH$1,334 · 3
By mechanism
M01$1,334 · 3
Top collaborators
No co-investigators on record.
Most similar at Children'S Hospital Boston
Same institution · by research overlap
- Robert N Husson$14,997,727
- Sally Radovick$22,223,944
- Raif Salim Geha$43,046,244
- Richard S Blumberg$53,904,839
- Jordan Scott Orange$15,778,537
Others in their field
Top investigators on “Human Subject”
- Sonia M Thomas · Research Triangle Institute$701,865,642
- Tracy L Nolen · Research Triangle Institute$474,487,152
- George R Seage · Abt Associates, Inc.$172,422,660
- Jay Arnold Tischfield · Rutgers, The State Univ Of N.J.$160,455,836
- Jeffrey P Krischer · University Of South Florida$155,493,283
- Charles A Coltman · Southwest Oncology Group$154,811,913
Research focus
Human SubjectCystic FibrosisClinical ResearchMetabolism Disorder ChemotherapyPharmacokineticsHuman Therapy EvaluationClinical Trial Phase IDrug /AgentRespiratory InfectionsMembrane ProteinsMultidrug ResistanceMycobacteriumPathologic ProcessPseudomonasRecombinant ProteinsBlood ChemistrySecretionCytokineDrug Screening /EvaluationEndotoxinsGram Negative BacteriaImmunogeneticsIntravenous AdministrationLipopolysaccharides
Grant awards (6)
ORAL MULTIDOSE CPX IN ADULTS WITH CYSTIC FIBROSIS$0
M01 · FY2002 · RR
ORAL MULTIDOSE CPX IN ADULTS WITH CYSTIC FIBROSIS$0
M01 · FY2001 · RR
ORAL MULTIDOSE CPX IN ADULTS WITH CYSTIC FIBROSIS$0
M01 · FY2001 · RR
M/C INVESTIGATION OF NTM MYCOBACTERIA IN PATIENTS WITH CYSTIC FIBROSIS$667
M01 · FY2000 · RR
OPEN LABEL TRIAL OF RBPI21 TO ASSESS SAFETY &PHARMACOKINETICS IN CF$667
M01 · FY2000 · RR
ORAL MULTIDOSE CPX IN ADULTS WITH CYSTIC FIBROSIS$0
M01 · FY2000 · RR